Brain Age Estimation on T2 ‐ FLAIR Scans for Application to Multiple Sclerosis
Human Brain Mapping · 01.04.2026 · 47 (5)
DOI: 10.1002/hbm.70425 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Human Brain Mapping, online erschienen am 19.03.2026. Verfasst von Jordan Colman und 33 weiteren Autor:innen. Beteiligte Einrichtung: UCL Hawkes Institute, University College London, London, UK. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Multiple Sclerosis, Brain, Aging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ECTRIMS-MAGNIMS and ESNR, German Federal Ministry for Education and Research, BMBF, German Competence Network Multiple Sclerosis, Czech Ministry of Education.
Abstract (Originalsprache)
The brain‐predicted age difference (brain‐PAD) is associated with measures of clinical interest in people with multiple sclerosis (pwMS). Most brain age models rely on 3D T1‐weighted scans, which are not routinely acquired in MS clinical practice, limiting their potential for clinical translation. We aimed to develop a model predicting brain age using T2‐FLAIR, the core sequence for MS diagnosis and monitoring, and validate the resulting brain‐PAD values as a biomarker of MS severity and progression. We collected 3D T2‐FLAIR and 3D T1‐weighted brain MRI scans to compose (i) a multicentre cohort of healthy participants for brain age modeling, and (ii) a single‐centre cohort of pwMS and healthy controls for external validation. We trained and evaluated 3D convolutional neural network models predicting brain age from T2‐FLAIR or T1‐weighted images. Models were compared using t‐tests based on bootstrapped standard errors. Saliency maps were obtained with the SmoothGrad method to visualize regions that were most important for the predictions. Finally, using a linear model framework, we clinically validated the resulting brain‐PAD metric by assessing its relationship with diagnosis (MS versus healthy controls), clinical phenotype, disease duration, and physical disability as measured with the Expanded Disability Status Scale (EDSS), adjusting for age and sex. The Inception‐ResNet‐V2 model based on T2‐FLAIR scans yielded accurate brain age predictions (test set MAE = 3.31 years, R 2 = 0.944, 5x ensemble MAE = 2.81, R 2 = 0.955), which were comparable to those obtained with the T1w‐based model (test set MAE = 3.34 years, R 2 = 0.942, 5x ensemble MAE = 2.84, R 2 = 0.955, p = 0.91). Brain age predictions were mostly driven by subcortical regions, particularly the thalamus. T2‐FLAIR‐based brain‐PAD was higher in pwMS than healthy controls (7.07 vs −0.50 years, p < 0.0001). As with T1 brain‐PAD, FLAIR brain‐PAD correlated with MS disease duration ( R = 0.24, p < 0.0001) and EDSS ( R = 0.30, p < 0.0001). Brain age predictions relying on T2‐FLAIR scans are as accurate as those derived from T1‐weighted scans and could be used as an easily obtainable biomarker of MS severity and progression in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- UCL Hawkes Institute, University College London, London, UK.
- Department of Neuroradiology, King's College Hospital, London, UK.
- Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, UK.
- MS Center Amsterdam, Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, Amsterdam, the Netherlands.
- Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.
- Bayer Plc, Reading, UK.
ORCID-Profile: Michael A Foster, Gabriel Gonzalez-Escamilla, Lars T Westlye, Maria A Rocca, Massimo Filippi, Barbara Bellenberg, James H Cole
Förderung
- ECTRIMS-MAGNIMS and ESNR
- German Federal Ministry for Education and Research, BMBF, German Competence Network Multiple Sclerosis
- Czech Ministry of Education
- National Institute for Neurological Research
- European Union
- Czech Ministry of Health
- MEDDAY pharmaceutical company
- Medical Research Council
Zitieren
APA
Colman, J., Pontillo, G., Goodkin, O., Foster, M. A., Mahmoudi, N., Wattjes, M. P., Brunetti, A., Gonzalez-Escamilla, G., Groppa, S., Høgestøl, E. A., Westlye, L. T., Messina, S., Palace, J., Cortese, R., De Stefano, N., Rovira, À., Sastre-Garriga, J., Ropele, S., Enzinger, C., …, & MAGNIMS Study Group (2026). Brain Age Estimation on T2 ‐ FLAIR Scans for Application to Multiple Sclerosis. Human Brain Mapping, 47(5). https://doi.org/10.1002/hbm.70425
Vancouver
Colman J, Pontillo G, Goodkin O, Foster MA, Mahmoudi N, Wattjes MP, et al. Brain Age Estimation on T2 ‐ FLAIR Scans for Application to Multiple Sclerosis. Human Brain Mapping. 2026;47(5). doi:10.1002/hbm.70425
BibTeX
@article{Colman2026,
author = {Colman, Jordan and Pontillo, Giuseppe and Goodkin, Olivia and Foster, Michael A and Mahmoudi, Nima and Wattjes, Mike P and Brunetti, Arturo and Gonzalez-Escamilla, Gabriel and Groppa, Sergiu and Høgestøl, Einar August and Westlye, Lars T and Messina, Silvia and Palace, Jacqueline and Cortese, Rosa and De Stefano, Nicola and Rovira, Àlex and Sastre-Garriga, Jaume and Ropele, Stefan and Enzinger, Christian and Rocca, Maria A and Filippi, Massimo and Bellenberg, Barbara and Lukas, Carsten and Calabrese, Massimiliano and Castellaro, Marco and Uher, Tomas and Vaneckova, Manuela and Toosy, Ahmed and Ciccarelli, Olga and Yousry, Tarek and Prados, Ferran and Barkhof, Frederik and Cole, James H and MAGNIMS Study Group, MAGNIMS Study Group},
title = {Brain Age Estimation on T2 ‐ FLAIR Scans for Application to Multiple Sclerosis},
journal = {Human Brain Mapping},
year = {2026},
volume = {47},
number = {5},
doi = {10.1002/hbm.70425}
}
EUVIMED